Literature DB >> 25239771

Coatings from blends of Eudragit® RL and L55: a novel approach in pH-controlled drug release.

R Wulff1, C S Leopold2.   

Abstract

The aim of the present study was to investigate the drug release from theophylline pellets coated with blends of quaternary polymethacrylate and methacrylic acid-ethyl acrylate copolymers. Pellets were coated with blends of Eudragit(®) RL PO (RL) and Eudragit(®) L 100-55 (L55) in either organic solution or aqueous dispersion at various copolymer ratios. Generally, the coatings were less permeable for theophylline in phosphate buffer pH 6.8 than they were in hydrochloric acid pH 1.2. Further dissolution experiments revealed that the differences in drug release are caused by the different pH values. A design of experiments for historical data was performed on drug release data of pellets with different coating levels and blend ratios of RL and L55. Drug release in hydrochloric acid was predominantly affected by the coating level, whereas for drug release in phosphate buffer pH 6.8 the blend ratio was the determining factor. As expected, dissolution experiments at different pH values showed that drug release depends on the ratio of dissociated L55 to RL because ionization is a requirement for the functional groups to interact. With the dissolution test for delayed-release solid dosage forms (Ph. Eur.) it was demonstrated that the unique release behavior in neutral media is preserved after the exposition to hydrochloric acid. These findings indicate that the combination of RL and L55 in coatings prepared from solutions is a promising approach for controlled drug release.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Controlled drug release; Interpolyelectrolyte complex; Polymer blend; Quaternary polymethacrylate; Response surface methodology; pH-dependent drug release

Mesh:

Substances:

Year:  2014        PMID: 25239771     DOI: 10.1016/j.ijpharm.2014.09.023

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  Coatings of Eudragit® RL and L-55 Blends: Investigations on the Drug Release Mechanism.

Authors:  Robert Wulff; Claudia S Leopold
Journal:  AAPS PharmSciTech       Date:  2015-08-12       Impact factor: 3.246

2.  Sustained-release solid dispersion of pelubiprofen using the blended mixture of aminoclay and pH independent polymers: preparation and in vitro/in vivo characterization.

Authors:  Yeo-Song Lee; Jae Guen Song; Sang Hoon Lee; Hyo-Kyung Han
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

3.  A second-generation micro/nano capsules of an endogenous primary un-metabolised bile acid, stabilized by Eudragit-alginate complex with antioxidant compounds.

Authors:  Armin Mooranian; Nassim Zamani; Momir Mikov; Svetlana Goločorbin-Kon; Goran Stojanovic; Frank Arfuso; Bozica Kovacevic; Hani Al-Salami
Journal:  Saudi Pharm J       Date:  2019-12-07       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.